Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | January 03, 2013

When Government Treads on Medical Practice

When Government Treads on Medical Practice

Dense breast tissues make mammograms (right) difficult to read, which may require complementary testing, such as MRI (left). Efforts by state legislatures mandating that physicians inform patients of the challenges of dense breast imaging raise both opportunity and risk for radiologists. Image courtesy Agfa Healthcare

For many years mammographers have been saddled with low reimbursements. Recognizing this, women’s health advocates lobbied successfully over the last decade for higher rates for mammograms produced with digital equipment.  

This may be the only exception to the “rule of less” that has been applied to imaging reimbursements since the federal Deficit Reduction Act (DRA) took effect in 2007. Cutbacks in reimbursement have at the very least slowed the growth of medical imaging procedures and led to a decline in the purchase of new imaging equipment, just as the increased reimbursement for digital mammography led to a boom in the purchase of full field digital systems that today dominate the landscape of women’s health.

While the federal government has been content to influence the practice of medicine through financial dictates, lately individual state governments have taken a more direct approach. Five states now mandate physicians to inform women with dense breasts that mammography may be of limited value for them. Connecticut, Virginia, Texas, California and New York require physicians to advise patients that complementary imaging studies, such as ultrasound or MRI, may be needed if dense fibroglandular tissues are likely to obscure the mammographic signs of cancer.

This legislation offers opportunity for radiologists, who might do what the RSNA at its last annual meeting advised members to do: “Be the voice of radiology for your patients.” They might educate and inform patients about the significance of breast density, as they are doing at the Elizabeth Wende Breast Clinic in Rochester, New York. They might also provide complementary testing. It is logical to expect that they do so. But stepping into this breach carries risk. (Editor’s Note: For more information, see Legislating Women’s Health: A Chance for Radiologists to Step In by Greg Freiherr at http://www.itnonline.com/content/legislating-women%E2%80%99s-health-chance-radiologists-step.)

Third party payers in the first states to adopt such mandated education have typically reimbursed for the ultrasound procedures that may follow, although such reimbursement is not required by law. And while ultrasound coverage may be provided, it is seldom there for the MRI exams that might be indicated for women with dense breasts at high risk of developing cancer. When reimbursement is not available, the laws do not address who should shoulder the costs.

And there are logistical challenges, as well. Few mammography practices have the capacity to perform ultrasound immediately following the determination that a patient has dense breasts. Even fewer can accommodate an MRI exam the same day. Patients found to have dense breasts and prescribed a complementary exam, therefore, may have to return for another appointment or travel to another facility, neither of which may be easy, particularly if they have traveled a long way already for their mammogram.  

Then there are fundamental problems with ultrasound and MRI. Their high sensitivity and lack of specificity lead inevitably to more biopsies and a preponderance of negative findings for procedures that otherwise would not have been performed, as illustrated by early experiences in the first state to enact such legislation, Connecticut.1

Consequently, legislative efforts of this type amount to little more than unfunded mandates that impose costs on insurance companies, practitioners and patients. While they may provide an opportunity for radiologists to become more involved with patients, radiologists must be careful in how they respond to this opportunity, as these mandates may expose them to risks that can endanger the very relationships that the mandates foster.

At least when the federal government seeks to influence medical practice, it foots the bill … albeit at a cut rate.

 

Reference:

1.  Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology. 2012;265:59-69. Abstract: http://www.medscape.com/medline/abstract/22723501

 


Related Content

News | Computed Tomography (CT)

SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...

Time August 06, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
News | Breast Imaging

July 29, 2024 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the ...

Time July 29, 2024
arrow
News | Breast Imaging

July 29, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time July 29, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiology Business

July 25, 2024 — The radiology gender gap is decreasing, but there remains work to be done, according to an editorial ...

Time July 25, 2024
arrow
Subscribe Now